GLP-1 management, beyond the prescription.
GLP-1 therapy works when patients stick with it. We wrap pharmacist support around the first 12 months — titration coaching, side-effect management, adherence interventions — so therapy lasts longer than the first refill.
GLP-1 attrition is a pharmacy problem.
Roughly half of GLP-1 patients discontinue within 6 months. Most reasons are addressable at the pharmacy: side effects, injection anxiety, dose escalation pacing, lifestyle anchors. We give your pharmacists the cadence and tools to intervene at each drop-off point.
Best for the GLP-1 cohort — weight-management or T2D indication.
First 90 days — nausea, dose pacing, injection technique.
Months 3–6 — the highest discontinuation window.
Months 6+ — lifestyle anchors and adherence sustainment.
The Medsense app keeps GLP-1 patients on therapy past the rough months.
Built alongside our pharmacist team and tested with real GLP-1 patients — the app is the daily-rhythm layer between pharmacy check-ins.
Once-weekly reminders, injection-site rotation guidance, and a log the Medsense care team can see at their next check-in.
Patients flag severity in seconds. Persistent or severe entries route to the pharmacist same day, before they become discontinuation events.
Weekly weigh-ins paired with smart-scale support. We surface trajectory and plateaus instead of asking patients to obsess over a daily number.
Plain-language guidance on the titration schedule, what to expect at each step, and how to talk to the prescriber about pacing.
Secure messaging with the Medsense care team. Most messages answered same business day; titration questions escalate to the prescriber.
Short, daily prompts focused on the three habits that protect muscle mass and tolerability while on GLP-1 therapy.